We are live on ! Find out more
BL

Balentine LLC Portfolio holdings

AUM $2.48B
1-Year Est. Return 17.44%
This Fund
S&P 500
This Quarter Est. Return
+2.07%
1 Year Est. Return
+17.44%
3 Year Est. Return
+46.33%
5 Year Est. Return
+51.14%
10 Year Est. Return
+189.48%
AUM
$506M
AUM Growth
+$112M
Cap. Flow
+$100M
Cap. Flow %
19.82%
Top 10 Hldgs %
90.28%
Holding
476
New
144
Increased
131
Reduced
39
Closed
20

Top Buys

Rank Stock Value
1
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$36.9M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$32.4M
3
DFJ icon
WisdomTree Japan SmallCap Dividend Fund
DFJ
+$9.64M
4
IAU icon
iShares Gold Trust
IAU
+$7M
5
RWR icon
State Street SPDR Dow Jones REIT ETF
RWR
+$5.69M

Top Sells

Rank Stock Value
1
BW icon
Babcock & Wilcox
BW
+$2.66M
2
SFST icon
Southern First Bancshares
SFST
+$1.07M
3
VGK icon
Vanguard FTSE Europe ETF
VGK
+$902K
4
RY icon
Royal Bank of Canada
RY
+$447K
5
ADP icon
Automatic Data Processing
ADP
+$257K

Sector Composition

Rank Sector Weight
1 Technology 3.25%
2 Energy 2.52%
3 Consumer Staples 2.49%
4 Financials 1.93%
5 Industrials 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NX icon
351
Quanex
NX
$854M
$10K ﹤0.01%
560
+50
+10% +$935
OGS icon
352
ONE Gas
OGS
$5.05B
$10K ﹤0.01%
150
-80
-35% -$4.82K
WTS icon
353
Watts Water Technologies
WTS
$11.5B
$10K ﹤0.01%
180
– –
YUM icon
354
Yum! Brands
YUM
$41B
$10K ﹤0.01%
167
– –
ZBH icon
355
Zimmer Biomet
ZBH
$17.7B
$10K ﹤0.01%
88
+59
+203% +$6.68K
ICPT
356
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$10K ﹤0.01%
+67
New +$9.77K
BW icon
357
Babcock & Wilcox
BW
$1.43B
$9K ﹤0.01%
64
-12,474
-99% -$2.66M
CE icon
358
Celanese
CE
$5.09B
$9K ﹤0.01%
130
– –
COF icon
359
Capital One
COF
$124B
$9K ﹤0.01%
140
– –
FET icon
360
Forum Energy Technologies
FET
$654M
$9K ﹤0.01%
26
– –
LAZ icon
361
Lazard
LAZ
$4.37B
$9K ﹤0.01%
+307
New +$10.6K
MEI icon
362
Methode Electronics
MEI
$543M
$9K ﹤0.01%
270
– –
MELI icon
363
Mercado Libre
MELI
$91.3B
$9K ﹤0.01%
+67
New +$8.7K
MO icon
364
Altria Group
MO
$122B
$9K ﹤0.01%
+132
New +$8.45K
REGN icon
365
Regeneron Pharmaceuticals
REGN
$68.8B
$9K ﹤0.01%
+27
New +$10.4K
STZ icon
366
Constellation Brands
STZ
$22.2B
$9K ﹤0.01%
53
– –
CPE
367
DELISTED
Callon Petroleum Company
CPE
$9K ﹤0.01%
+80
New +$8.57K
CIR
368
DELISTED
CIRCOR International, Inc
CIR
$9K ﹤0.01%
155
-20
-11% -$1.07K
AYI icon
369
Acuity Brands
AYI
$9.88B
$8K ﹤0.01%
+32
New +$7.99K
CAT icon
370
Caterpillar
CAT
$409B
$8K ﹤0.01%
107
+1
+0.9% +$75
CB icon
371
Chubb
CB
$140B
$8K ﹤0.01%
+62
New +$7.64K
DVAX
372
DELISTED
Dynavax Technologies
DVAX
$8K ﹤0.01%
+554
New +$9.47K
ITGR icon
373
Integer Holdings
ITGR
$3.35B
$8K ﹤0.01%
250
– –
ITRI icon
374
Itron
ITRI
$3.73B
$8K ﹤0.01%
190
– –
IVZ icon
375
Invesco
IVZ
$13.3B
$8K ﹤0.01%
330
– –
13 14
15
16 17

Similar funds

FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $2.48B AUM 72.25% 1-Year Est. Return
JC
JB Capital Wethersfield, Connecticut $2.48B AUM 22.31% 1-Year Est. Return
TW
Trajan Wealth Scottsdale, Arizona $2.48B AUM 17.44% 1-Year Est. Return
Q
QVR San Francisco, California $2.49B AUM 48.58% 1-Year Est. Return
SIM
Stratos Investment Management Beachwood, Ohio $2.49B AUM 17.24% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
M
Mirova Paris, France $2.46B AUM 11.42% 1-Year Est. Return

Balentine LLC's Q2 2016 Portfolio in Review

As of Q2 2016, Balentine LLC held 476 positions worth $506M, up 28% from $394M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Balentine LLC deployed $100M of net new capital in Q2 2016, opening 144 new positions and adding to 131 existing holdings. Its largest new stake was Enterprise Products Partners: 18,807 shares worth $550K.

By sector, the portfolio is most concentrated in Technology at 3.3% of assets, down from 4% a quarter earlier, followed by Energy and Consumer Staples.

On the sell side, the largest reduction was Babcock & Wilcox, an estimated $2.66M trimmed.

  • Balentine LLC's largest Q2 2016 buy was Enterprise Products Partners: 18,807 shares worth $550K.
  • Balentine LLC added most to iShares Russell 1000 Growth ETF in Q2 2016, an estimated $36.9M increase.
  • Balentine LLC's biggest Q2 2016 reduction was Babcock & Wilcox, cutting an estimated $2.66M.
  • Balentine LLC fully exited Southern First Bancshares in Q2 2016, selling an estimated $1.07M.
  • Balentine LLC's ten largest holdings make up 90% of its $506M portfolio in Q2 2016.
  • Balentine LLC opened 144 new positions and closed 20 in Q2 2016.
  • Balentine LLC's portfolio value rose 28% quarter-over-quarter to $506M.

Based on Balentine LLC's 13F filing for Q2 2016, filed 16 Aug 2016.